Combined treatment with buserelin and cyproterone acetate in metastatic male breast cancer
- 15 July 1993
- Vol. 72 (2) , 502-505
- https://doi.org/10.1002/1097-0142(19930715)72:2<502::aid-cncr2820720228>3.0.co;2-1
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- RANDOMISED CONTROLLED STUDY OF ORCHIDECTOMY VS LONG-ACTING D-TRP-6-LHRH MICROCAPSULES IN ADVANCED PROSTATIC CARCINOMAThe Lancet, 1985
- Des lead-in to use of luteinizing hormone releasing hormone analogs in treatment of metastatic carcinoma of prostateUrology, 1985
- Hormonal Treatment of Disseminated Male Breast CancerOncology, 1985
- Leuprolide versus Diethylstilbestrol for Metastatic Prostate CancerNew England Journal of Medicine, 1984
- Antitumor Effects of Analogs of Hypothalamic Hormones in Endocrine-Dependent CancersExperimental Biology and Medicine, 1984
- TREATMENT WITH A LUTEINISING-HORMONE-RELEASING-HORMONE ANALOGUE (BUSERELIN) IN PREMENOPAUSAL PATIENTS WITH METASTATIC BREAST CANCERThe Lancet, 1982
- Treatment of Advanced Prostatic Cancer with Parenteral Cyproterone Acetate: A Phase III Randomised Trial*British Journal of Urology, 1980
- Male breast cancer: a reviewCancer Treatment Reviews, 1976
- Male Breast Cancer: Two Cases with Objective Regressions from Calusterone (7α, 17β-dimethyltestosterone) after Failure of OrchiectomyOncology, 1976
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958